Bannari Amman Sugars Limited (BANARISUG) Fair Value & Analysis
Consumer Defensive · IN · Market cap ₹42.5B
Fair value as of: Jun 29, 2026
Analysis
Bannari Amman Sugars Limited (BANARISUG) currently trades at ₹3,378, while our model-based Fair Value estimate is ₹2,005 — implying the stock looks roughly 40.6% overvalued today. We read business quality at 97/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Bannari Amman Sugars Limited engages in the manufacture and sale of sugar in India. The company operates through Sugar, Power, Distillery, and Granite Products segments. It manufactures and sells cane crush; industrial alcohol and extra neutral spirits; polished granite products; and bio and agri natural fertilizer products, including capsules, fertilizers, fungicides, insecticides, nematicides, stimulants, decomposing cultures, enriched organic manures, micronutrient mixtures, organic manures. The company also generates power through co-generation power plants and windmills. It also exports its products. It sells its products to traders, institutions, and retail customers through distributors and direct sales channels. Bannari Amman Sugars Limited was incorporated in 1983 and is based in Coimbatore, India.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Bannari Amman Sugars Limited (BANARISUG) undervalued?
What is the fair value of BANARISUG?
What is the quality score of BANARISUG?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.